Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Novel transcript, antisense to FKBP8 (ENSG00000269191) is a long non-coding RNA (lncRNA) gene located antisense to the FKBP8 locus. It is categorized as a non-protein-coding transcript, and there is currently no experimental evidence describing its biological function, disease roles, or direct involvement in drug interactions. The gene is notable primarily for its genomic relationship to FKBP8, which encodes a known FK506-binding protein. No biological or clinical roles have been established for this specific lncRNA to date[1][3]. This molecule is defined as an lncRNA and not as a classical receptor, enzyme, or drug target, and there is no evidence at present of it having established function, biomarker utility, or disease association in major databases[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, antisense to FKBP8.